Bulk Inquiry
Sabizabulin
- VERU111- Soluble in DMSO
- MF: C21H19N3O4
- MW: 377.39
Description
Sabizabulin is an orally bioavailable and highly potent inhibitor of tubulin polymerization with an average IC50 value of 3.8 nM (five tested cancer cell lines).
More Information
| Parent CAS No. | 1332881-26-1 |
|---|---|
| Chemical Name | (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl)methanone |
| SMILES | C1(OC)C(OC)=C(OC)C=C(C(C2=CNC(C3C4C=CC=CC=4NC=3)=N2)=O)C=1 |
| MFCD | N.A. |
| InChi | InChI=1S/C21H19N3O4/c1-26-17-8-12(9-18(27-2)20(17)28-3)19(25)16-11-23-21(24-16)14-10-22-15-7-5-4-6-13(14)15/h4-11,22H,1-3H3,(H,23,24) |
| InChiKey | WQGVHOVEXMOLOK-UHFFFAOYSA-N |
| CID | 53379371 |
| Short Description | Tubulin inhibitor |
References
- J Chen et al. Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents. J Med Chem. 2012 Aug 23;55(16):7285-9.
- VK Kashyap et al. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Lett. 2020 Feb 1;470:64-74.
- RI Krutilina et al. Sabizabulin, a Potent Orally Bioavailable Colchicine Binding Site Agent, Suppresses HER2+ Breast Cancer and Metastasis. Cancers (Basel). 2022 Oct 29;14(21):5336.
Related Products
| AXON ID | NAME | FROM PRICE |
|---|---|---|
| 1233 | Combretastatin-A4 |
From $93.50 |
| 1310 | Myoseverin |
From $137.50 |
| 1650 | HTI 286 |
From $154.00 |
| 2398 | Suprafenacine |
From $121.00 |
| 2658 | MPT0B098 |
From $121.00 |
| 2815 | SP-6-27 |
From $137.50 |
| 2816 | WX-132-18B |
From $126.50 |
| 2916 | Cevipabulin |
From $154.00 |
| 3083 | PVHD121 |
From $132.00 |
| 3243 | CK-666 |
From $110.00 |
| 3368 | Podophyllotoxin |
From $44.00 |
| 3371 | Colchicine |
From $55.00 |
| 3400 | Tubulin inhibitor 6 |
From $99.00 |
Other Categories
Are you sure you would like to remove this item from the shopping cart?
This item is a part of the approved quote. Removing it will remove all quote items from the cart.


